Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment

被引:302
作者
Lesokhin, Alexander M. [3 ]
Hohl, Tobias M. [5 ]
Kitano, Shigehisa [4 ]
Cortez, Czrina
Hirschhorn-Cymerman, Daniel
Avogadri, Francesca
Rizzuto, Gabrielle A. [6 ]
Lazarus, John J. [7 ]
Pamer, Eric G. [2 ,3 ]
Houghton, Alan N. [2 ,3 ]
Merghoub, Taha
Wolchok, Jedd D. [1 ,3 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10065 USA
[2] Cornell Univ, Grad Sch Med Sci, Ithaca, NY 14853 USA
[3] Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA
[4] Ludwig Inst Canc Res, NY Branch, New York, NY USA
[5] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA
[6] Univ Calif San Francisco, San Francisco Med Ctr, San Francisco, CA 94143 USA
[7] Univ Toledo, Coll Med, Toledo, OH 43606 USA
关键词
COLONY-STIMULATING FACTOR; GM-CSF DNA; MELANOMA PATIENTS; INFLAMMATORY MONOCYTES; CANCER-PATIENTS; BEARING MICE; PHASE-I; VACCINE; RESPONSES; IDENTIFICATION;
D O I
10.1158/0008-5472.CAN-11-1792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that accumulate during tumor formation, facilitate immune escape, and enable tumor progression. MDSCs are important contributors to the development of an immunosuppressive tumor microenvironment that blocks the action of cytotoxic antitumor T effector cells. Heterogeneity in these cells poses a significant barrier to studying the in vivo contributions of individual MDSC subtypes. Herein, we show that granulocyte-macrophage colony stimulating factor, a cytokine critical for the numeric and functional development of MDSC populations, promotes expansion of a monocyte-derived MDSC population characterized by expression of CD11b and the chemokine receptor CCR2. Using a toxin-mediated ablation strategy to target CCR2-expressing cells, we show that these monocytic MDSCs regulate entry of activated CD8 T cells into the tumor site, thereby limiting the efficacy of immunotherapy. Our results argue that therapeutic targeting of monocytic MDSCs would enhance outcomes in immunotherapy. Cancer Res; 72(4); 876-86. (C) 2011 AACR.
引用
收藏
页码:876 / 886
页数:11
相关论文
共 44 条
[1]   GM-CSF plus antigenic peptide vaccination in locally advanced melanoma patients [J].
Atzpodien, Jens ;
Reitz, Martina .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (04) :551-555
[2]   Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center [J].
Bergman, PJ ;
Camps-Palau, MA ;
McKnight, JA ;
Leibman, NF ;
Craft, DM ;
Leung, C ;
Liao, J ;
Riviere, I ;
Sadelain, M ;
Hohenhaus, AE ;
Gregor, P ;
Houghton, AN ;
Perales, MA ;
Wolchok, JD .
VACCINE, 2006, 24 (21) :4582-4585
[3]   Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients [J].
Bins, Adriaan ;
Mallo, Henk ;
Sein, Johan ;
van den Bogaard, Colette ;
Nooijen, Willem ;
Vyth-Dreese, Florry ;
Nuijen, Bastiaan ;
de Gast, Gijsbert C. ;
Haanen, John B. A. G. .
JOURNAL OF IMMUNOTHERAPY, 2007, 30 (02) :234-239
[4]  
Bronte V, 1999, J IMMUNOL, V162, P5728
[5]   A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients [J].
Cassaday, Ryan D. ;
Sondel, Paul M. ;
King, David M. ;
Macklin, Michael D. ;
Gan, Jacek ;
Warner, Tom F. ;
Zuleger, Cindy L. ;
Bridges, Alan J. ;
Schalch, Heidi G. ;
Kim, Kyung Mann ;
Hank, Jacquelyn A. ;
Mahvi, David M. ;
Albertini, Mark R. .
CLINICAL CANCER RESEARCH, 2007, 13 (02) :540-549
[6]  
Chang David Z, 2004, Hematology, V9, P207, DOI 10.1080/10245330410001701549
[7]   Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF [J].
Dolcetti, Luigi ;
Peranzoni, Elisa ;
Ugel, Stefano ;
Marigo, Ilaria ;
Fernandez Gomez, Audry ;
Mesa, Circe ;
Geilich, Markus ;
Winkels, Gregor ;
Traggiai, Elisabetta ;
Casati, Anna ;
Grassi, Fabio ;
Bronte, Vincenzo .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (01) :22-35
[8]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[9]   Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Vaccination with an Allogeneic Whole-Cell Melanoma Vaccine [J].
Faries, Mark B. ;
Hsueh, Eddy C. ;
Ye, Xing ;
Hoban, Mary ;
Morton, Donald L. .
CLINICAL CANCER RESEARCH, 2009, 15 (22) :7029-7035
[10]   Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains [J].
Ferrone, Cristina R. ;
Perales, Miguel-Angel ;
Goldberg, Stacie M. ;
Somberg, C. Joy ;
Hirschhorn-Cymerman, Daniel ;
Gregor, Polly D. ;
Turk, Mary Jo ;
Ramirez-Montagut, Teresa ;
Gold, Jason S. ;
Houghton, Alan N. ;
Wolchok, Jedd D. .
CLINICAL CANCER RESEARCH, 2006, 12 (18) :5511-5519